Study of GnRH-A [Leuprorelin(Lorelin Depot] Plus Leterozole +/- Everolimus for Premenopausal Women With Metastatic Breast Cancer

NCT02344550 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

137

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Everolimus(afinitor)
DRUG: Letrozole
DRUG: Leuprolide(Lorelin Depot)

Sponsor

Asan Medical Center